Foff Erin Pennock: insider trades.
Foff Erin Pennock reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($1.7M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 9
- Companies
- 1
- Name as filed
- Foff Erin Pennock
Companies
| Company | Relationship | Transactions |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | Officer · Chief Medical Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-17 | MapLight Therapeutics, Inc. | A | 13,360 | $0 | 312,261 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 3,656 | $37.9 | 298,901 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 19 | $37.96 | 302,557 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 5,865 | $37.26 | 302,576 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 9,163 | $36.46 | 308,441 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 4,465 | $36 | 326,594 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 8,972 | $36.99 | 317,622 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 7,845 | $37.04 | 331,059 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 7,155 | $36.16 | 338,904 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 18 | $37.54 | 317,604 | Form 4 |
Questions
What stock did Foff Erin Pennock buy or sell?
Foff Erin Pennock reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($1.7M), across 1 company.
Is Foff Erin Pennock the same person as other filers with this name?
This page covers SEC CIK 2021233 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/foff-erin-pennock-2021233.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.